Events

December 2, 2024 (1:00-2:30PM PANEL) Evaluation of Novel Psychoactive Substances’ Patterns of Use, Trends & Risks: A Growing Challenge for Public Health Experts & Policy Silvia Martins (Columbia Mailman) – Moderator; Charles Branas (Columbia Mailman); Theoklis Zaoutis (Columbia Global Center in Athens) Elena Deligianni (Columbia Global Center in Athens); and Daniel Freedberg (Columbia, Medicine)

The Herbert and Florence Irving Institute for Cancer Dynamics will continue its seminar series on the topic of mathematical sciences underpinning cancer research. The monthly seminars take place on the second Wednesday of the month, 2:00-3:00 PM EST. The presentations are open to the Columbia community (in person and online) and to researchers outside Columbia (via Zoom). On Wednesday, December 4th (2:00 PM ET), IICD welcomes Livnat Jerby, Assistant Professor, Department of Genetics, Stanford University. Seminar hosted by Sanja Vickovic. The seminar will take place in person in Schermerhorn Hall 603 (Morningside Heights campus). If you wish to attend the seminar remotely, please register using the following link: https://columbiauniversity.zoom.us/meeting/register/tJUqfu6tpjkqGdH9-POf628HWa-Q_vsFwPx9   Title: TBA Abstract: TBA Bio: Livnat Jerby is an Assistant Professor in the Department of Genetics at Stanford University, a Chan Zuckerberg Biohub Investigator, and a Paul Allen Distinguished Investigator. Livnat leads a multidisciplinary research team that is pursuing novel avenues to tackle fundamental challenges in studying and leveraging multicellular processes as a disease driver and therapeutic modality. Using engineering-based, high-throughput approaches, her laboratory develops "hybrid" platforms across in-vitro/in-vivo/in-silico systems to identify new immunomodulating mechanisms and interventions. Recent work from her lab uncovered previously underappreciated aspects of the anti-tumor immune response and new modalities for immune cell engineering. Before joining Stanford, Livnat was a postdoctoral fellow in Aviv Regev’s lab at the Broad Institute of MIT and Harvard. She was among the first to use single cell genomics to study resistance to immunotherapy directly in patients and subsequently in combination with single cell CRISPR screens. Livnat holds a BSc in Computer Science and Biology and obtained her PhD from Tel Aviv University, where she worked with Eytan Ruppin, studying genetic interactions in cancer. Her work has been supported by the Cancer Research Institute, the Burroughs Wellcome Fund, Ovarian Cancer Research Alliance, Schmidt Family Foundation, Rothschild Foundation, Paul G. Allen Family Foundation, Bill and Melinda Gates Foundation, Chan Zuckerberg Biohub initiative, and the National Institute of Health.   If you would like to meet one-on-one (possibility via zoom) or attend the lunch or dinner with the speaker, please contact the event organizer.    

Register on Zoom This training session will cover: Opioid overview What an opioid overdose is Signs and symptoms of an opioid overdose What increases the risk of opioid overdose Medication for opioid use disorders What naloxone is and how it works Naloxone kit: components and use Response steps for a suspected overdose How to administer naloxone Distribution of naloxone kits Naloxone trainings are currently offered virtually via Zoom to all members of the Columbia community, including affiliates on the Morningside/Manhattanville campus and Columbia University Irving Medical Center. Naloxone kits will be available for pickup from Columbia Health or mailed to participants upon completion of training. *Columbia Health is a Registered Opioid Overdose Prevention Program, recognized by New York City and State Departments of Health. This designation came as part of a collaboration with researchers from the Mailman School of Public Health and the School of General Studies. Learn more about our Opioid Education and Naloxone Training program on our website.  Columbia University makes every effort to accommodate individuals with disabilities. If you require closed captioning, sign-language interpretation, or any other accommodation, please contact Disability Services at (212) 854-2388 or disability@columbia.edu at least 10 days in advance. Contact Information Columbia Health health@columbia.edu

This program will be of interest to general pediatricians who are interested in expanding their knowledge in a variety of subspecialty areas with new or updated guidelines or practice parameters that impact primary pediatric care. In particular, healthcare providers who do not feel comfortable in recognizing or managing patients with the above conditions will benefit from this conference. The subspecialty topics covered in the conference deal with conditions that generally involve a team approach for patient care, including the primary care physician and the subspecialist. The conference will provide the primary care physician with practical information that will help them to become more knowledgeable in identifying, understanding, and co-managing a variety of complex conditions along with the subspecialist. The conference will also provide an opportunity for the primary care physicians to ask questions directly to the participating subspecialists to further enhance their understanding of the conditions discussed. The combination of didactic and interactive elements will promote a more effective learning experience. SOME TOPICS TO BE COVERED INCLUDE: Food Allergy  Antibiotics for Soft tissue and Skin Infections Updates on PCOS Diagnosis and Management Dyslipidemia  Type 2 Diabetes Updates SMART therapy for Asthma Eosinophilic Esophagitis Identification and Management Positive Parenting Cannabis Use and Hyperemesis  Updates on Tonsillectomy and Adenoidectomy  New Acne Guidelines Updates on Scoliosis Screening and Management Mental Health Update: Bipolar Disorder in Children